Skip to Main Content

Paper Details

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma.
Commun Biol
5
2022
Astatine-211, CB57/BL6, High-, High-risk neuroblastomas, PARP1, PDX models, [At], [At]PTT, astatine-211, cancer, cancer cells, high-, high-risk neuroblastoma, mice, mouse, parthanatine, patient, poly(adenosine-diphosphate-ribose), poly(adenosine-diphosphate-ribose) polymerase 1, solid tumors, tumor, tumors
Author NameAffiliation
Khushbu PatelDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Jennifer PogorilerChildren's Hospital of Philadelphia
Jennifer PogorilerChildren's Hospital of Philadelphia
Daniel MartinezChildren's Hospital of Philadelphia
Daniel MartinezChildren's Hospital of Philadelphia
Alvin FarrelDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
John M MarisDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
John M MarisPerelman School of Medicine at the University of Pennsylvania
John M MarisDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
John M MarisPerelman School of Medicine at the University of Pennsylvania
  • 1 - 10

Datasets

Release 1.2